Literature DB >> 18713821

Oxysterol as a marker of atherogenic dyslipidemia in adolescence.

Dalal Alkazemi1, Grace Egeland, Jacob Vaya, Sara Meltzer, Stan Kubow.   

Abstract

CONTEXT: Oxysterols represent potentially important oxidative stress biomarkers in adolescence.
OBJECTIVE: The objective of the study was to examine the relationship between the concentrations of serum enzymatically and nonenzymatically generated oxysterols, measures of obesity, and metabolic components including insulin resistance and levels of blood pressure and serum lipids.
DESIGN: This was a cross-sectional study.
SETTING: All subjects were examined between 2003 and 2005 at a hospital, a part of a follow-up evaluation mother-daughter pairs representing pregnancies affected or unaffected by gestational diabetes that resulted in the deliveries in 1989-1991.
SUBJECTS: Subjects included a subset (n=89) of the total study population of 189 adolescent girls with a mean age of 15.32+/-0.65 yr and body mass index of 22.54+/-3.98 kg/m2. MAIN OUTCOME MEASURES: Measures included serum levels of the oxysterols 7alpha-hydroxy-cholesterol, 7beta-hydroxycholesterol, and 7-ketocholesterol; and body mass index, homeostasis model assessment insulin resistance index, fasting insulin, fasting glucose, blood pressure, total cholesterol, non-high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and apolipoprotein B (ApoB).
RESULTS: Serum oxysterol concentrations in the adolescent cohort correlated positively with insulin (P<0.05), total cholesterol (P<0.05), non-high-density lipoprotein cholesterol (P<0.05), low-density lipoprotein cholesterol (P<0.05), and ApoB (P<0.01). ApoB and fasting insulin were found to be the major determinants of serum oxysterols after adjustment for body mass index. Being a daughter of gestational diabetes pregnancy alone did not seem to be a predisposing factor to increased oxidative stress in our cohort.
CONCLUSION: Serum oxysterol concentrations increase with obesity, insulin, and ApoB, which are established derangements associated with the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713821     DOI: 10.1210/jc.2008-0586

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Abnormal cholesterol is associated with prefrontal white matter abnormalities among obese adults, a diffusion tensor imaging study.

Authors:  Jessica I Cohen; Fanny Cazettes; Antonio Convit
Journal:  Neuroradiol J       Date:  2011-11-15

2.  Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease.

Authors:  Forbes D Porter; David E Scherrer; Michael H Lanier; S Joshua Langmade; Vasumathi Molugu; Sarah E Gale; Dana Olzeski; Rohini Sidhu; Dennis J Dietzen; Rao Fu; Christopher A Wassif; Nicole M Yanjanin; Steven P Marso; John House; Charles Vite; Jean E Schaffer; Daniel S Ory
Journal:  Sci Transl Med       Date:  2010-11-03       Impact factor: 17.956

3.  Evaluation of apoptotic molecular pathways for smooth muscle cells isolated from thoracic aortic aneurysms in response to oxidized sterols.

Authors:  Zelal Adiguzel; Nazli Arda; Omer Kacar; Muge Serhatli; Serpil Gezer Tas; Ahmet Tarik Baykal; Kemal Baysal; Ceyda Acilan
Journal:  Mol Biol Rep       Date:  2014-09-30       Impact factor: 2.316

4.  Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study.

Authors:  Kelly Fellows Maxwell; Sonia Bhattacharya; Mary Lou Bodziak; Dejan Jakimovski; Jesper Hagemeier; Richard W Browne; Bianca Weinstock-Guttman; Robert Zivadinov; Murali Ramanathan
Journal:  J Lipid Res       Date:  2019-05-13       Impact factor: 5.922

5.  Risk of gestational diabetes mellitus in relation to maternal egg and cholesterol intake.

Authors:  Chunfang Qiu; Ihunnaya O Frederick; Cuilin Zhang; Tanya K Sorensen; Daniel A Enquobahrie; Michelle A Williams
Journal:  Am J Epidemiol       Date:  2011-02-15       Impact factor: 4.897

Review 6.  Metabolic syndrome as a risk factor for neurological disorders.

Authors:  Akhlaq A Farooqui; Tahira Farooqui; Francesco Panza; Vincenza Frisardi
Journal:  Cell Mol Life Sci       Date:  2011-10-15       Impact factor: 9.261

Review 7.  Lymphocyte roles in metabolic dysfunction: of men and mice.

Authors:  Blanche C Ip; Andrew E Hogan; Barbara S Nikolajczyk
Journal:  Trends Endocrinol Metab       Date:  2015-01-05       Impact factor: 12.015

8.  Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring.

Authors:  Eleanor Jarvie; Sylvie Hauguel-de-Mouzon; Scott M Nelson; Naveed Sattar; Patrick M Catalano; Dilys J Freeman
Journal:  Clin Sci (Lond)       Date:  2010-04-28       Impact factor: 6.124

9.  Association of oxysterol binding protein-related protein 9 polymorphism with cerebral infarction in Hunan Han population.

Authors:  Lingjuan Li; Geyue Qu; Mingyue Wang; Qing Huang; Yunhai Liu
Journal:  Ir J Med Sci       Date:  2013-11-05       Impact factor: 1.568

10.  Maternal hypercholesterolemia enhances oxysterol concentration in mothers and newly weaned offspring but is attenuated by maternal phytosterol supplementation.

Authors:  Jerad H Dumolt; Sandhya K Radhakrishnan; Mohammed H Moghadasian; Khuong Le; Mulchand S Patel; Richard W Browne; Todd C Rideout
Journal:  J Nutr Biochem       Date:  2017-09-28       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.